Previous 10 | Next 10 |
Livemoney news releases related Livemoney news releases and Livemoney press releases from 09/17/20 11:58:40 on US and Canada Markets.
Stocks dropped on Thursday as technology shares declined. The major averages, however, recovered most of their earlier losses as names that would benefit from the economy reopening rebounded. The Dow Jones Industrial Average had done some catching up by noon EDT, but was still in the r...
Stocks dropped on Thursday as technology shares declined, along with plays related to a successful coronavirus vaccine rollout. The Dow Jones Industrial Average fell back 104.26 points to 27,928.12. The S&P 500 slid 22.11 points to 3,363.38. The NASDAQ trudged lower 119.26 poi...
U.S. stock futures dropped as technology stocks declined, along with plays related to a successful coronavirus vaccine rollout. Futures for Dow Jones Industrials tumbled 232 points, or 0.8%, early Thursday, to 27,705. Futures for the S&P 500 slumped 42 points, or 1.2%, at 3,337.5...
The Dow Jones Industrial Average eked out a small gain on Wednesday after the Federal Reserve indicated it will keep interest rates lower over the next few years. However, the broader market S&P 500 struggled as shares of major tech companies declined. The 30-stock index retreated ...
The Dow Jones Industrial Average and S&P 500 were both higher on Wednesday as traders awaited the Federal Reserve's latest decision on monetary policy. The Dow Jones Industrials popped 230.88 points to 28,226.48. The S&P 500 took on 16.28 points to 3,417.81. The NASDAQ in...
U.S. stock futures rose in early trading Wednesday as investors readied for comments from the Federal Reserve later in the day. Futures for Dow Jones Industrials vaulted 101 points, or 0.4%, early Wednesday, to 28,009. Futures for the S&P 500 tacked on 14.5 points, or 0.4%, at 3,...
Unfortunately, glioblastoma is an aggressive brain tumor that still remains difficult to treat. To this day, there is still an unmet need for treatment, with only 8.7% of patients surviving for up to two years, according to Tactical Therapeutics. However, it appears some companies are making ...
Unfortunately, glioblastoma is an aggressive brain tumor that still remains difficult to treat. To this day, there is still an unmet need for treatment, with only 8.7% of patients surviving for up to two years, according to Tactical Therapeutics. However, it appears some companies are making ...
Stocks rose on Tuesday, building on the strong performance from the previous session, on the back of broad market gains and solid economic data. The Dow Jones Industrials gave back most of what it had gained on the day, finished up only 2.27 points to 27,995.60. The S&P 500 hung ...
Stocks jumped on Tuesday, building on the strong performance from the previous session, on the back of further tech gains and solid economic data. The Dow Jones Industrials remained positive by Tuesday noon, 106.36 points to 28,099.69. The S&P 500 progressed 31.57 points to 3,415...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
9.15%Change Percent:
CBIZ Inc. Company Name:
CBZ Stock Symbol:
NYSE Market:
cbiz.com Website: